RxDoctor Payments Data

Jenna Harmon

Psychiatric/Mental Health · Louisville, KYNPI 1366164501

Payments from drug & device makers

$4,921in general payments, 2019–2025

Across 320 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$697
  • Supernus Pharmaceuticals, Inc.$537
  • Bausch Health US, LLC$463
  • Corium, LLC$429
  • Vanda Pharmaceuticals Inc.$423
  • Lundbeck LLC$396
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,921 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide21$9,905
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$1,328
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine24$567
Aripiprazole12$446
Lithium Carbonate ErLithium Carbonate13$261
Duloxetine Hcl13$260
Alprazolam29$192
Mirtazapine16$185
Methylphenidate Hcl14$124
Clonazepam25$100
Lorazepam15$68
Zolpidem Tartrate11$9

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$25$9,90521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →